Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Ethnopharmacological relevance</h3><p>The <em>Dang-Gui-Si-Ni</em> (DGSN) decoction as a classic prescription has been widely used for thousands of years in the clinical practice of traditional Chinese medicine (TCM). Especially in recent years, the potential efficacy of TCM for the treatment of Raynaud's syndrome has attracted great attention as there are still no specific remedies for this disease. However, the active constituents and underlying mechanisms responsible for the therapeutic benefits are not well understood, which makes it difficult to ensure quality control or to design research and drug development strategies. To identify the potential pharmacodynamic ingredients (PPIs) of TCM will help to achieve suitable process control procedures for industrial production and large-scale manufacturing.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aim of the study</h3><p>In the present study, we propose a multi-dimensional qualitative analysis method combining water-decoction spectra, <em>in-vitro</em> intestinal absorption spectra, <em>in-vivo</em> plasma spectra, and molecular docking of components to quickly identify the PPIs for the DGSN decoction of TCM.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3><p>Water-based decoctions of DGSN were prepared in accordance with the clinical use registered in ancient books. Ultra-high-performance liquid chromatography-quadrupole-time of flight mass spectrometry (UHPLC-Q/TOF-MS) coupled with computerized modelling activity screening was used to quickly identify the PPIs of the DGSN decoction. Bioactive compounds absorbed <em>in vitro</em> were identified using the everted intestinal sac model from rats and compounds absorbed <em>in vivo</em> were confirmed in portal vein blood samples obtained following oral administration in rats. Molecular docking validation experiments were adopted to predict the binding activity to coagulation factors I, II, VII, X, and IX. The active components were further confirmed by pharmacodynamics analysis. The anticoagulant activity of the DGSN decoction was verified using rat models.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Thirty-one compounds were identified in the DGSN decoction. According to the <em>in vivo</em> experiments, 22 compounds that could be absorbed <em>in vivo</em> were detected by the everted intestinal sac model in rats. This model greatly reduces the scope of PPIs and is easy to perform. Ten compounds were detected in the portal vein blood in rats. The compounds detected in plasma provide stronger evidence supporting the PPIs. Molecular docking <em>in vitro</em> experiments indicated that 7 compounds exhibited better binding activity with coagulation factors I, II, VII, X, and IX. The animal experiments confirmed that the DGSN decoction could improve the microcirculation, providing indirect proof of anticoagulant activity suggested by the molecular docking studies. Finally, based on the multi-dimensional methods, 9 potential compounds present in the DGSN decoction were identified as PPIs (i.e., ferulic acid, paeoniflorin, albiflorin, chlorogenic acid, cryptochlorogenic acid, liquiritin, liquiritin apioside, cinnamaldehyde and glycyrrhizic acid).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Overall, this study combined the water-decoction spectra, intestinal absorption spectra <em>in vitro</em>, plasma spectra <em>in vivo,</em> and molecular docking studies to establish a multi-dimensional qualitative analysis method of the DGSN decoction. Meanwhile, 9 compounds in DGSN decoction were identified as PPIs using this method, and are proposed for application as quality standards for complex TCM prescriptions.</p>

Docking-Based Computational Analysis of Guava (Psidium guajava) Leaves Derived Bioactive Compounds as Coagulation Factor IXa Inhibitor

Docking-based computational analysis of guava (Psidium guajava) leaves derived bioactive compounds as a coagulation factor IXa inhibitor

Molecular Dynamics and Free Energy Perturbation Analysis of Guava (Psidium guajava) Leaf-Derived Inhibitors Against Coagulation Factor IXa

Fishing the Targets of Bioactive Compounds from Psidium guajava L. Leaves in the Context of Diabetes

Using Multiscale Molecular Modeling to Analyze Possible NS2b-NS3 Protease Inhibitors from Philippine Medicinal Plants

Study on Chemical Composition and Biological Activity of Psidium guajava Leaf Extracts

In-vitro and in-silico analyses of the thrombolytic potential of green kiwifruit

Investigation of the chemical composition of antibacterial Psidium guajava extract and partitions against foodborne pathogens

Identification and Anticoagulant Mechanisms of Novel Factor XIa Inhibitory Peptides by Virtual Screening of a in Silico Generated Deep-Sea Peptide Database

Antibiofilm and anti-quorum sensing activity of Psidium guajava L. leaf extract: In vitro and in silico approach

Discovery of potential pharmacodynamic ingredients of Dang-Gui-Si-Ni decoction based on absorbed ingredients and molecular docking

A review on pharmaceutical and environmental applications of guava (Psidium guajava) leaves

Guava (Psidium guajava L. cv. Red Suprema) Crude Extract Protect Human Dermal Fibroblasts against Cytotoxic Damage Mediated by Oxidative Stress

In-silico screening and identification of potential drug-like compounds for dengue-associated thrombocytopenia from Carica papaya leaf extracts

Cleavable Novel Thienopyridine Derivatives as Potent Antithrombotic Agents

Identifying of Anti-Thrombin Active Components From Curcumae Rhizoma by Affinity-Ultrafiltration Coupled With UPLC-Q-Exactive Orbitrap/MS

Guava (Psidium guajava L.) Leaf Extract as Bioactive Substances for Anti-Androgen and Antioxidant Activities

The phytochemistry and medicinal value of Psidium guajava (guava)

Network pharmacology analysis of pharmacological mechanisms underlying the anti-type 2 diabetes mellitus effect of guava leaf

A Network-Based Multi-Target Computational Estimation Scheme for Anticoagulant Activities of Compounds.

Intermediate molecular weight-fucosylated chondroitin sulfate from sea cucumber Cucumaria frondosa is a promising anticoagulant targeting intrinsic factor IXa